Key result
Multimodality treatment consisting of chemotherapy, surgery, and radiotherapy has improved five-year survival rates from 5-10% to 40% in adult patients with Ewing sarcoma.
Population
Adults with Ewing sarcoma (primary bone tumours)
Design
Review
Authors
Loading...
Supports multimodality therapy for adults with Ewing sarcoma; leaves open optimal regimens and prospective validation.
Advances in multidisciplinary treatment, including combined chemotherapy, surgery, and radiotherapy, have significantly improved quality of life and prognosis for patients with Ewing sarcoma.
Świtaj et al. (2019) conducted a review in Ewing sarcoma. Multimodality treatment was evaluated. Multimodality treatment consisting of chemotherapy, surgery, and radiotherapy has improved five-year survival rates from 5-10% to 40% in adult patients with Ewing sarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: